Katrina is a licensed veterinary technician and earned her bachelor’s degree in business from Thomas College.
Autogenous Capabilities Support Poultry Industry Needs
Autogenous Capabilities Support Poultry Industry Needs
Autogenous vaccines are an important poultry industry tool, providing an option to customize your vaccine program based on field challenges rather than relying solely on what commercial vaccines can provide for protection. They fill a void when:
Elanco Animal Health has recently expanded their autogenous capabilities to include small batch serials ranging from 300,000 to 600,000 doses to serve customers needing a smaller-than-traditional serial, such as turkey or layer producers, or those customers that require a more focused approach with a regional or complex-based challenge.
Elanco Animal Health has a dedicated 9,600-square-foot autogenous facility in Winslow, Maine, with its own manufacturing team to produce autogenous vaccines.
Common Autogenous Vaccines Produced
Elanco commonly produces autogenous vaccines to address a variety of viral and bacterial disease in turkeys, layers and broiler breeders, including autogenous vaccines for type A influenza strains in turkeys. The most common organisms include:
Autogenous vaccine adjuvants offered include water-oil, water-oil-water and aluminum hydroxide. Elanco can also provide concentrated or 1/2 cc dose options.
Emerging Disease Issues
Autogenous vaccines are a solid solution for producing a customized vaccine in a relatively short time to address an emerging disease issue or a novel variant of an existing disease.
For example, reovirus is a constantly moving target for many poultry producers and Salmonella target serovars can vary among producers.
The Autogenous Vaccine Process
The autogenous vaccine production process is the same for large and small batch vaccines and typically takes 12 to 18 weeks.
Selecting an Autogenous Vaccine Partner
The autogenous vaccine production process can be confusing and frustrating. I encourage poultry producers and veterinarians to collaborate with a manufacturer that can provide trust and open communication. Our role as a manufacturer is to help guide customers through the process and develop a product manufactured to the same quality standards as our commercial vaccines.
For more information on autogenous vaccine options, download this information sheet or contact your Elanco technical consultant.
Reovirus
Salmonella
vaccine
Layers
Turkey
Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2021 Elanco.
PM-US-20-1639